INO
Inovio Pharmaceuticals Inc
1.20$
+2.2%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -7,494.1% | -25,597.2% | – | -27,996.0% | – | -16,807.6% | -41,127.6% | – | – | – | – | – | – | |
| 265.9% | 170.7% | – | 822.4% | – | 663.1% | 1,137.8% | – | – | – | – | – | – | |
| 535.3% | 2,207.8% | – | 1,502.6% | – | 1,124.6% | 2,141.5% | – | – | – | – | – | – | |
| 2,875.2% | – | – | – | – | – | – | – | – | – | – | – | – | |
| -1,900.4% | -2,056.5% | – | 1,763.4% | – | -624.9% | -7,306.0% | – | – | – | – | – | – | |
| 0.0% | 312.6% | – | 448.8% | – | 0.0% | 90.9% | – | – | – | – | – | – | |
| -1,414.3% | 19,428.2% | – | 9,890.9% | – | 29,612.1% | -79.2% | – | – | – | – | – | – | |
| – | 445.2% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | 0.0% | 0.0% | – | – | – | – | – | – | |
| 179.9% | 1,790.8% | – | 32,783.8% | – | 24,911.9% | 1,573.1% | – | – | – | – | – | – | |
| -8,729.1% | -4,377.7% | – | 14,678.7% | – | 37,716.3% | -39,633.7% | – | – | – | – | – | – | |
| -7,494.1% | -25,284.6% | – | -28,444.9% | – | -16,807.6% | -41,218.5% | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.